Experts discussed challenges and opportunities for dose optimization of cancer treatments at the 2025 AACR-Industry Roundtable.
Guest post by William G. Nelson, MD, PhDEditor-in-Chief, Cancer Today Mutant HRAS, KRAS, or NRAS genes have been found in...
Guest post by the Biopharma Collaborative Core Team In 2019, AACR Project GENIE (Genomics Evidence Neoplasia Information Exchange) embarked...
Our five senses provide us with the crucial information we need to interact with the world. On a physiological...
About 80 percent of breast cancers express the estrogen receptor (ER). In ER-positive tumors, estrogen is the main driver...
From a joyous opening performance from the Preservation Hall All-Stars to a closing plenary that highlighted the full spectrum...
Accounting for less than 1 percent of all newly diagnosed cancers in the United States each year, sarcomas are...
For June, the editors of the AACR’s 10 journals chose to spotlight a characterization of an investigational KRAS inhibitor,...
Gregory J. Aune, MD, PhD, is a renowned pediatric oncologist with a powerful story. At age 16, he was...
June 2022 marked the 10th Annual Cancer Immunotherapy Month spearheaded by the Cancer Research Institute. Immunotherapy is an umbrella...
Although childhood cancer is rare, it represents the leading cause of death by disease in children in developed countries....